Citigroup’s Axsome Therapeutics AXSM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $17.2M | Buy |
|
|||||
|
2025
Q2 | $8.87M | Buy |
|
|||||
|
2025
Q1 | $4.57M | Sell |
|
|||||
|
2024
Q4 | $3.63M | Buy |
|
|||||
|
2024
Q3 | $3.2M | Buy |
|
|||||
|
2024
Q2 | $1.35M | Sell |
|
|||||
|
2024
Q1 | $7.59M | Sell |
|
|||||
|
2023
Q4 | $8.1M | Sell |
|
|||||
|
2023
Q3 | $7.18M | Buy |
|
|||||
|
2023
Q2 | $4.51M | Buy |
|
|||||
|
2023
Q1 | $2.98M | Buy |
|
|||||
|
2022
Q4 | $3.13M | Sell |
|
|||||
|
2022
Q3 | $2.16M | Sell |
|
|||||
|
2022
Q2 | $2.29M | Buy |
|
|||||
|
2022
Q1 | $370K | Sell |
|
|||||
|
2021
Q4 | $464K | Sell |
|
|||||
|
2021
Q3 | $1.54M | Buy |
|
|||||
|
2021
Q2 | $512K | Buy |
|
|||||
|
2021
Q1 | $338K | Sell |
|
|||||
|
2020
Q4 | $1.08M | Buy |
|
|||||
|
2020
Q3 | $801K | Sell |
|
|||||
|
2020
Q2 | $16.8M | Buy |
|
|||||
|
2020
Q1 | $700K | Buy |
|
|||||
|
2019
Q4 | $862K | Buy |
|
|||||
|
2019
Q3 | $51K | Buy |
|
|||||
|
2019
Q2 | $1K | Sell |
|
|||||
|
2019
Q1 | $265K | Buy |
|
|||||
|
2017
Q3 | – | Sell |
|
|||||
|
2017
Q2 | $0 | Sell |
|
|||||
|
2017
Q1 | $0 | Sell |
|
|||||
|
2016
Q4 | $23K | Buy |
|
|||||
|
2016
Q3 | $7K | Sell |
|
|||||
|
2016
Q2 | $8K | Buy |
|